PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106, Braunschweig, Germany.\', \'Helmholtz Centre for Infection Research, Department of Viral Immunology, Inhoffenstr. 7, 38124, Braunschweig, Germany.\', \'Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, 27100, Pavia, Italy.\', \'Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.\', \'Abcalis GmbH, Science Campus Braunschweig-Süd, Inhoffenstr. 7, 38124, Braunschweig, Germany.\', \'Department of Anesthesiology, Reanimation, Intensive Care and Emergency Medicine, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.\', \'Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.\', \'Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy.\', \'Department of Epidemiology, Helmholtz Centre for Infection Research, Inhoffenstr. 7, 38124, Braunschweig, Germany.\', \'Centre for Individualised Infection Medicine (CIIM), a joint venture of Helmholtz Centre for Infection Research and Medical School Hannover, Hannover, Germany.\', \'Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106, Braunschweig, Germany. m.hust@tu-bs.de.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12916-022-02312-5
?:doi
?:hasPublicationType
?:journal
  • BMC medicine
is ?:pmid of
?:pmid
?:pmid
  • 35236358
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.219
?:rankingScore_hIndex
  • 98
is ?:relation_isRelatedTo_publication of
?:title
  • Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all